The Canadian Competition Authority encourages interested parties to share their views with the task force examining the effects of pharmaceutical mergers

Interested parties encouraged to share views with task force examining effects of pharmaceutical mergers* Through its participation in the Multilateral Pharmaceutical Merger Task Force, the Competition Bureau, with its counterparts in the U.S., the European Union and the U.K., is

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Canadian Competition Bureau, The Canadian Competition Authority encourages interested parties to share their views with the task force examining the effects of pharmaceutical mergers, 11 May 2021, e-Competitions May 2021, Art. N° 101082

Visites 138

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues